Many patients in need of a haematopoietic cell transplant cannot find a suitable HLA-compatible donor within their families and rely on volunteers who have registered as haematopoietic stem cell donors with a stem cell donor registry. Transplant physicians mostly prefer male donors for their patients when multiple donor options exist, and organizations recruiting donors are actively targeting males in their recruitment efforts. However, significant recruitment of female donors continues worldwide and appears to be increasing. In this review, the evidence underlying transplant physician preference for male donor selection is summarized. The review will inform donor recruitment organizations contemplating a change in strategy to target potential male registrants and will equip donor recruitment staff and volunteers with a resource to better understand their recruitment efforts.
Introduction
Over 70% of patients who need a stem cell or bone marrow transplant cannot find a suitable human leukocyte antigen (HLA)-matched donor in their family and require an alternative donor to proceed with treatment. Unrelated donors remain the most common alternative donor choice for allogeneic transplantation [1] . Haploidentical and umbilical cord donors both represent emerging sources of stem cells [1] .
Adult unrelated donors are recruited in 57 countries [2] . Individuals are invited to join as potential volunteer stem cell donors by providing informed consent as well as a DNA sample (through a buccal swab, blood sample or saliva sample). Registrants' HLA typing is listed in an international database. Transplant physicians can search the global inventory using their national registry.
The best donor for allogenic haematopoietic stem cell transplant (HSCT) is an allele-level HLA-matched donor [3] . Moreover, younger individuals (i.e. up to age 35) should be preferentially recruited and selected, as these donors are associated with improved survival in transplant recipients [4, 5] . Younger individuals can also remain on the registry longer once they have signed up and are less likely to be cytomegalovirus (CMV) positive than older donors [5] . Finally, individuals from a diversity of ethnic backgrounds should be targeted for recruitment, as patients are more likely to find an HLA-matched unrelated donor within their own ethnic groups [6] . Many ethnic and racial minority groups experience lower rates of finding HLA-matched donors, both within [7-10] and outside [11] [12] [13] of North America. This is due to the combination of smaller donor pools, disproportionate representation on individual registries and on the worldwide network, and ethnic/racial differences in genetic diversity and in attrition from stem cell donor databases [14] . In addition, the transplant community has demonstrated a preference for selecting male donors, as reflected in recent British Society for Histocompatibility and Immunogenetics donor selection guidelines [15] .
Data available from several registries show that the majority of registrants who are selected to donate are males. In the US National Marrow Donor Program (NMDP) in 2007, 58% of donors selected for transplant were male [3] . A study by Mueller et al. examining newly recruited donors in Germany from 2008 to 2009 showed males were more commonly selected than young female donors, with an odds ratio of 2Á36 (P < 0Á05) [16] . More recent data from OneMatch at Canadian Blood Services show that 75% of donors selected for transplant are male (D. Mercer, personal communication, 20 November 2016).
Although males are selected more often as donors, the majority of registrants on international donor registries are female ( In this review, we summarize the evidence that supports current donor selection practices regarding donor sex, and we highlight the discrepancy between recruitment and selection of male donors. Our review will inform donor recruitment organizations contemplating a change in strategy to target potential male registrants and will equip donor recruitment staff and volunteers with a resource to better understand their recruitment efforts.
Male recipients of grafts from female donors have reduced survival rates and increased risk of treatment-related mortality
The importance of male donors was initially highlighted in studies demonstrating poor outcomes following female donor-male recipient (FDMR) sex mismatches.
Storb et al.
[17] were first to show evidence of higher transplant-related mortality in patients with aplastic anaemia who received sex-mismatched HSCT. Since then, worse outcomes associated with FDMR donor-recipient mismatches have been confirmed in a number of studies and disease settings [18] [19] [20] [21] . Today, many transplant physicians use the EBMT risk score to predict patients' risk of undergoing stem cell transplantation [22] . In this risk score, a point is added for transplants with the FDMR sex mismatch. FDMR mismatch predicts an increased risk of adverse outcomes after HSCT as compared to sexmatched donor-recipient pairs. This score it was originally applied only to patients with CML [23] . A subsequent analysis of more than 50 000 HSCTs over a time The total males on these registries divided by the total registrants (male and female) on these registries. The total males listed on these registries, divided by the total registrants in the world at the time.
[Correction added on 1 February 2018, after first online publication: superscripts for this Taken together, improved outcomes with sex-matched as compared to FDMR mismatched unrelated transplants in the majority of situations highlight the increased demand for male stem cell donors as compared to females. Further research is warranted to evaluate the value of selecting a female donor for a male recipient in specific cases (such as for younger donors with a high risk of relapse).
Patients with male donors are less likely to develop the post-transplant complication chronic graft-versus-host disease
The relationship between donor sex and development of chronic graft-versus-host disease (GvHD) in the transplant recipient has emerged as a particularly compelling argument in support of male donor selection and recruitment. In general, evidence supporting a relationship between donor sex and acute GvHD has been inconsistent, with some large retrospective studies supporting an association [30] and others showing none [4, 5] . However, evidence supporting a relationship between donor sex and chronic GvHD has been more convincing.
Several studies have only implicated parous females (having a history of one or more pregnancies) in increased risk of chronic GvHD. Loren et al. found that female donors were associated with increased risk of chronic GvHD regardless of parity. These authors performed a retrospective analysis using CIBMTR data from 1995 to 1999, examining the relationship between donor sex, parity and GvHD in 2626 adult recipients of allografts from HLA-identical adult siblings [31] . They found that, compared with male donors, parous female donors imparted a significantly greater risk of chronic GvHD (HR 1Á62; 95% CI 1Á40-1Á89; P < 0Á01), as did nulliparous female donors (HR 1Á38; 95% CI 1Á12-1Á71; P < 0Á003). Here, donor parity did not impact chronic GvHD rates.
Still other studies show that FDMR sex mismatches increase risk of chronic GvHD. Stern et al.
[30] retrospectively analysed donor/recipient sex combination in 53 988 transplant recipients reported to the EBMT between 1980 and 2005. The cumulative incidence of chronic GvHD was 43% in FDMR transplants compared to 35% in controls (P < 0Á001). A number of other studies have shown similar findings; however, none of these studies were able to obtain data on donor parity [19, 28, 32] .
To the best of our knowledge, only two retrospective studies have reported a lack of association between donor sex and an increased risk of chronic GvHD [33, 34] . However, both included smaller sample sizes (n = 709 and n = 225) and addressed specific patient populations, and neither examined donor parity as a variable.
The available evidence to date supports the association between male donors and decreased risk of chronic GvHD in recipients. These data present the most compelling rationale for the transplant community to preferentially select male donors in cases when multiple donor options are available; however, there are several caveats which must be considered. It is important to note that the increased rates of chronic GvHD were not associated with increased mortality in the large retrospective studies by Kollman et al. [4, 5] . Moreover, the transplant community has other tools it could employ to reduce risk of chronic GvHD, such as collecting and transplanting bone marrow rather than peripheral blood stem cells [35] . Finally, not all male recipients of female stem cells will develop chronic GvHD. Refinements in our knowledge of the factors which predict development of chronic GvHD may guide the transplant community to more readily select women as donors.
Higher cell counts in peripheral blood progenitor cell collections from male donors Available evidence strongly suggests that cell counts in PBSC collections from male donors are greater than from females. For this reason, transplant centres may consider male donors when other factors are equal, to optimize the cell dose. Alternately, the above data could support the notion that female unrelated donors should be asked to donate bone marrow; this would also lower the risk of recipients developing chronic GVHD [35] .
Male unrelated donors have fewer adverse events associated with donation
An important consideration for the transplant physician is the donor experience, and male unrelated donors have been shown to experience fewer adverse events related to donation compared with females. In a review on stem cell donor experience, Billen et al. [55] highlight that female bone marrow and PBSC donors are associated with a higher risk of donation-related toxicities and adverse reactions. Women donating PBSCs are more likely to experience pain, fatigue, nausea, vomiting and sideeffects of hypocalcaemia [49, [56] [57] [58] [59] [60] [61] . Similarly, female bone marrow donors are more likely to experience toxicities including pain and fatigue and are less likely to experience complete recovery [62] [63] [64] [65] . With both procedures, women were more likely to require extended hospitalization following donation [58, 59], experience greater physical difficulty with donation [58, 63, 65, 66] and develop more serious complications [64] . Female PBSC donors were also more likely than males to require a central line, a more invasive procedure itself associated with risks including bleeding, infection and pneumothorax [57, 61] . It is important to note that data related to adverse events are regulated and therefore captured systematically only for unrelated donors. Adverse events for family donors are unknown, as, other than from case reports, there is no regular systematic follow-up. The increased rate of adverse events in female unrelated donors suggests that males have less difficulty with donation and highlights the need for awareness and proactive management of toxicities and adverse events in females.
Donor sex, availability and attrition
Donor recruitment organizations who are contemplating a shift towards focussed recruitment of males should be aware of the impact this may have on donor availability. Decreased availability can contribute to adverse patient outcomes [7, 67] , and recruitment organizations therefore need to work to ensure that the donors they recruit are available if asked to donate.
In a 2014 paper, Lown et al. [68] examined the relationship between attrition and sex on the Anthony Nolan registry. They found that female registrants were more likely to be unavailable to donate (OR = 1Á32, P < 0Á001), primarily due to medical ineligibility as a result of pregnancy. However, although males were more available, they were also more likely to be noncontactable than females (39Á9% vs. 33Á7%). Lown et al.'s findings contrast with several studies of registrants on the NMDP, which did not find a relationship between sex and attrition at key decision points leading up to donation [69] [70] [71] . Improved understanding of changing donor demographics on availability and attrition can help registries to refine their retention strategies.
Donor sex in cord blood haematopoietic cell transplantation
Cord blood represents an alternative source of donation, though the importance of donor sex here is unclear. Total nucleated cell count (TNC) and CD34 + cell count are two markers of cord blood quality, and both have been associated with engraftment post-transplant [72, 73] . Multiple studies have shown that cord blood units collected from female infants have higher TNCs than those collected from males [74] [75] [76] [77] [78] [79] [80] To the best of our knowledge, three retrospective studies have examined the impact of donor-recipient sex matching on recipient outcomes following single cord blood transplant for haematologic malignancy [89-91]. Baron et al. [89] found that male recipients of female cord blood donors had a lower leukaemia-free survival both in univariate (30% vs. 41%, P = 0Á01) and multivariate (HR = 1Á4, P = 0Á04) analysis, with a trend towards lower overall survival as well. However, no impact of donor sex was seen on chronic GvHD incidence [89]. Konuma et al.'s [90] study did not show any impact on survival, but did show a higher incidence of chronic GvHD in male recipients of female cord blood donors (HR 2Á97, P = 0Á02). Finally, a recent analysis by Zhu et al.
[91] showed that the EBMT score, in which female donor-male recipient sex matches are scored as higher risk, was a good predictor of outcomes including overalland leukaemia-free survival. However, these studies were limited by small sample sizes (n = 191, n = 207 and n = 552) and potential confounders. Further research is needed to clarify whether sex of the cord blood donor impacts clinical outcomes.
Sex and willingness to register
One factor which may be contributing to the increased proportion of female registrants is their increased willingness to register. Galanis et al.
[92] surveyed of 565 Greek people, of which 250 were registered stem cell donors, and they identified sex as an independent predictive factor for registering as a potential donor (with an OR of 2Á2 in favour of females registering). Another study by Studts et al. surveyed 102 US medical students about their attitudes towards stem cell donation and found that females scored significantly higher on a seven-point Likert scale assessing likelihood of registration (4Á92 -1Á54 vs. 4Á00 -1Á75, P < 0Á01) [93] . Importantly, both of these studies had significant limitations, including small sample sizes and unclear generalizability given the specific cultural, societal, professional and socioeconomic backgrounds of the participants. However, they support the hypothesis that males are a more challenging demographic to recruit.
Economic implications of targeted recruitment strategies
In addition to the evidence, donor recruitment organizations need to consider the economic consequences of targeted recruitment strategies. Donor registries are compensated for each match they facilitate. Furthermore, there is a cost associated with the recruitment of each registrant. Given the clear preference of transplant physicians for male donors, it is economically advantageous to recruit and register males, as they are more likely to be selected for transplant, all other factors being equal. The ability to fulfil the request of a client (i.e. the transplant centre) is a competitive advantage, regardless of the evidence supporting that request.
Male-focussed recruitment strategies
In cases where the donor recruitment organization decides to expand recruitment of male registrants, revisions to the donor recruitment strategy may be warranted. These could include the development and publication of marketing materials targeted at registering males ages 17-35, for example the 'Be The Guy' campaign developed by the nonprofit organization Be The Match of the US National Marrow Donor Program (see http://theinspirationroom.c om/daily/2016/be-the-match-be-the-guy/).
Further, recruiter training can be revised to coach recruiters to specifically encourage males. Recruitment organizations can track drive and recruiter success in terms of number of male registrants recruited, alongside other important metrics (including number of ethnically diverse registrants recruited and commitment and knowledge of recruits following registration). Finally, stem cell drives could be hosted at venues that males frequent.
Few male-specific recruitment strategies have been described in the literature. Anthony Nolan's partnership with the British Army, Royal Air Force, police and fire departments brought in 7Á5% of Anthony Nolan's event recruitment between 10/2012 and 01/2013, of which 85% were men [94] . The organization 'Marrow' is a network of 40 student groups who are based in universities with medical schools around the United Kingdom [94] . These groups are supported by Anthony Nolan and generally recruit a 50-50 split of university-aged male and female registrants [94] . Stem Cell Club is a similar initiative based at universities across Canada and partnered with OneMatch [95] . From 05/13 to 01/17, Stem Cell Club recruited 2877 males ages 17-35 (of whom 1255 self-identified as non-Caucasian), representing 8Á27% of the net increase in male registrants listed to OneMatch over the same time period [95] . Anthony Nolan's Register & Be a Lifesaver recruitment programme is delivered by volunteers in schools around the United Kingdom, with a roughly 50-50 split of male and female registrants reported [94] . Finally, success in recruitment of males has been reported in a rural setting [96] . O'Leary [94] notes that online donor recruitment is an important source of new registrants for Anthony Nolan, though less successful in targeted recruitment of males; from 10/12 to 01/13, 70% of online registrants were women. The reduced cost of online registration may need to incorporate aspects of more targeted campaigns aimed at recruiting males.
It is important to clarify that the task of shifting the demographics of the world's donor list is significant. From 2011 to 2015, the largest ten registries of the world recruited increasing proportions of female donors (Table 1A) . Throughout this time period, the net increase in total male registrants remained stable at 0Á75-1Á1 million annually (Table 2) . Furthermore, from 2011 to 2015, the top ten registries with the highest proportions of males managed a donor inventory of~62% male donors; the top three registries with the highest proportion of males managed a donor inventory of 68-77% male donors (Table 1B) . However, societal and cultural factors may have supported individual registries to recruit the highest proportions of males. Still, if recruitment rates worldwide remain constant at the current 2Á6 million net increase in HLA-typed donors annually [2], and supposing that 75% of these new donors will be male, then, in 10 years, males will make up 58Á8% of all donors -up from the present 44%. Moreover, even with recruitment organizations that have already made great efforts to recruit young male donors at stem cell drives, women are also able to register at drives and online. By denying women as donors, registries may lose them as ambassadors of stem cell donation and may therefore miss opportunities to recruit additional male donors.
As outlined above, there are many different strategies that recruitment organizations can employ, should they decide to pursue targeted recruitment of males, including changes in recruitment policy and approach or initiation of specific male-focused recruitment campaigns. However, registries may need to foster discussion in their jurisdiction regarding the extent to which males can be specifically recruited after considering ethical issues, resource constraints and the potential donor rights that may impact the registration process.
Conclusion
Males are more commonly selected by transplant centres but are underrepresented on worldwide registries and may be less willing to register. Though male recipients of female donors have been shown to have decreased posttransplant survival, the recent retrospective analysis by Kollman et al.
[4] did not find that donor sex impacted recipient survival. The most compelling reasons for preferential selection of male donors remain the reduced risk of chronic GvHD and the higher cell count yields with peripheral blood stem cell collections; however, both of these factors may be offset by harvesting bone marrow from female unrelated donors, instead of peripheral blood. Male donors also experience fewer adverse events associated with donation, and may have less attrition from registries compared with females, although aspects of donor retention and attrition remain under active study.
As outlined in the introduction, evidence supports donor-recipient HLA match and donor age as the most important considerations in donor selection. Moreover, recent donor selection guidelines from the British Society for Histocompatibility and Immunogenetics highlight that male donors should be preferentially chosen where the patient had multiple HLA-, CMV-and ABO-matched donors (Grade 1C Recommendation) [15] . These guidelines propose that donor-recipient CMV-match and ABOcompatibility should be prioritized over male donor selection. The optimal donor selection strategy with respect to donor sex remains unclear, and the transplant community will need to continue to examine their selection preferences with respect to donor sex.
Registries will need to rationalize the above studies with the transplant physician preference for male donors and decide how closely to align recruitment strategies with demand for male donors. Further, the relative importance of targeted recruitment of male registrants as compared to registrants who are younger and from a diversity of ethnic backgrounds remains an issue for individual recruitment organizations to address. Here, recruitment organizations need to consider not only the evidence, but economic considerations given the transplant community preference for selection of male donors.
Specific challenges for donor recruitment organizations in the foreseeable future related to targeted male donor recruitment include the use of effective male-specific recruitment strategies that include online methods. Ethical considerations regarding the rights and wishes of donors will also need to be addressed to maintain the goodwill Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on
